FR18C0002I1 - - Google Patents

Info

Publication number
FR18C0002I1
FR18C0002I1 FR18C0002C FR18C0002I1 FR 18C0002 I1 FR18C0002 I1 FR 18C0002I1 FR 18C0002 C FR18C0002 C FR 18C0002C FR 18C0002 I1 FR18C0002 I1 FR 18C0002I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30011928&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR18C0002(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR18C0002I1 publication Critical patent/FR18C0002I1/fr
Application granted granted Critical
Publication of FR18C0002I2 publication Critical patent/FR18C0002I2/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076—PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0624—Apparatus adapted for a specific treatment for eliminating microbes, germs, bacteria on or in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/08—Copper compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C07F15/0066—Palladium compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/04—Nickel compounds
    • C07F15/045—Nickel compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/06—Zinc compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
FR18C0002C 2002-11-17 2018-04-17 WATER-SOLUBLE ANIONIC BACTERIOCHLOROPHYL DERIVATIVES AND THEIR USES Active FR18C0002I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL15290002A IL152900A0 (en) 2002-11-17 2002-11-17 Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
PCT/IL2003/000973 WO2004045492A2 (en) 2002-11-17 2003-11-17 Water-soluble anionic bacteriochlorophyll derivatives and their uses

Publications (2)

Publication Number Publication Date
FR18C0002I1 true FR18C0002I1 (en) 2018-06-15
FR18C0002I2 FR18C0002I2 (en) 2020-03-13

Family

ID=30011928

Family Applications (1)

Application Number Title Priority Date Filing Date
FR18C0002C Active FR18C0002I2 (en) 2002-11-17 2018-04-17 WATER-SOLUBLE ANIONIC BACTERIOCHLOROPHYL DERIVATIVES AND THEIR USES

Country Status (24)

Country Link
US (6) US7947672B2 (en)
EP (2) EP1567147B1 (en)
JP (3) JP4922559B2 (en)
CN (2) CN102002048B (en)
AU (1) AU2003282354C1 (en)
BE (1) BE2018C018I2 (en)
BR (1) BRPI0316319B8 (en)
CA (1) CA2506296C (en)
CY (2) CY1115458T1 (en)
DK (1) DK1567147T3 (en)
ES (1) ES2489516T3 (en)
FR (1) FR18C0002I2 (en)
HK (1) HK1081858A1 (en)
HU (1) HUS1800020I1 (en)
IL (2) IL152900A0 (en)
LU (1) LUC00073I2 (en)
MX (1) MXPA05005262A (en)
NL (1) NL300934I2 (en)
NO (2) NO334978B1 (en)
NZ (1) NZ540790A (en)
PL (1) PL216661B1 (en)
PT (1) PT1567147E (en)
RU (1) RU2353624C2 (en)
WO (1) WO2004045492A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
CA2569675C (en) 2004-06-07 2015-03-17 Yeda Research And Development Co. Ltd Cationic bacteriochlorophyll derivatives and uses thereof
US9957293B2 (en) * 2006-08-23 2018-05-01 Yeda Research And Development Company Ltd. Conjugates of RGD peptides and porphyrin or (bacterio)chlorophyll photosynthesizers and their uses
MX2010009530A (en) 2008-02-27 2010-11-30 Yeda Res & Dev Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors.
EP2425873A1 (en) 2010-09-07 2012-03-07 Steba Maor SA Modelling of the action of optical fibre in a treatment by photodynamic therapy, and assistance in planning such a treatment
DK2683441T3 (en) 2011-03-11 2017-01-09 Steba Maor Sa PROCESSES FOR PLANNING focal PHOTO DYNAMIC THERAPY
JP6215203B2 (en) 2011-08-23 2017-10-18 イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ． Ｌｔｄ (Bacterio) chlorophyll photosensitizers for the treatment of eye diseases and disorders
MX360151B (en) 2013-03-11 2018-10-24 Tookad Ip Sarl Method for producing bacteriochlorophyll a.
US10766915B2 (en) 2013-03-15 2020-09-08 Sherri Ann McFARLAND Metal-based coordination complexes as photodynamic compounds and their use
JP2019510807A (en) * 2016-04-10 2019-04-18 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド Combination therapies for the treatment of cancer, including bacteriochlorophyll derivatives
CN107987081B (en) * 2016-10-26 2019-12-06 刘辉 Chlorin e6 derivative and pharmaceutically acceptable salt thereof, and preparation method and application thereof
CA3047893C (en) * 2016-12-22 2022-11-15 Daiichi Sankyo Company, Limited Spink2 peptide for preventing and/or treating age-related macular degeneration
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
EP3723785A1 (en) * 2017-12-17 2020-10-21 Yeda Research and Development Co. Ltd Cop9 signalosome (csn) complex modulators and uses thereof
CN111848656B (en) * 2020-06-24 2023-03-14 天津大学 Ion-modified protoporphyrin gallium compound and preparation method and application thereof
JPWO2022025043A1 (en) * 2020-07-29 2022-02-03
CN115843960A (en) * 2022-11-03 2023-03-28 中国农业科学院农产品加工研究所 Method for improving stability of chlorophyll

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512762A (en) 1982-11-23 1985-04-23 The Beth Israel Hospital Association Method of treatment of atherosclerosis and a balloon catheter for same
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
JPS63196586A (en) * 1987-02-12 1988-08-15 Toyo Hatsuka Kogyo Kk Bacteriopheophorbide derivative
ATE123749T1 (en) 1987-04-17 1995-06-15 David H Dolphin PORPHYRINS, PROCESS FOR THE PRODUCTION THEREOF AND USES.
US5004811A (en) 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
DE4121876A1 (en) 1991-07-02 1993-01-14 Scheer Hugo New modified bacterial chlorophyll derivs. - for diagnosis and treatment of tumours
JP3191223B2 (en) * 1991-10-04 2001-07-23 株式会社光ケミカル研究所 Porphyrin derivatives and their uses
EP0644759A4 (en) * 1992-06-19 1998-04-01 Univ Toledo Production and use of imines of porphyrins.
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
FR2712493B1 (en) * 1993-11-16 1996-01-19 Centre Nat Rech Scient Use of photosensitizers derived from the phorbine nucleus for the decontamination of blood infected by parasites and / or viruses.
JPH09110872A (en) 1995-10-23 1997-04-28 Eiken Chem Co Ltd Iodoporphyrin derivative
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them
GB9524553D0 (en) * 1995-11-30 1996-01-31 Britton Charles J Plastic lever lid tins
US5770730A (en) * 1996-03-08 1998-06-23 Health Research, Inc. Synthesis of carbodimide analogs of chlorins and bacteriochlorins and their use for diagnosis and treatment of cancer
WO1998014453A1 (en) * 1996-10-01 1998-04-09 Wyeth Lederle Japan, Ltd. Iminochlorinaspartic acid derivatives
IL129929A0 (en) * 1996-12-17 2000-02-29 Du Pont Polymerization of ethylene with specific iron or cobalt complexes novel pyridinebis (imines) and novel complexes of pyridinebis(imines) with iron and cobalt
PT1137411E (en) * 1998-12-09 2007-02-28 Yeda Res & Dev Palladium-substituted bacteriochlorophyll derivatives and use thereof
IL133253A0 (en) * 1999-12-01 2001-04-30 Yeda Res & Dev Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
JP4277159B2 (en) 2000-06-02 2009-06-10 独立行政法人科学技術振興機構 Novel tetrapyrrolyl-substituted porphyrin and its production method
WO2002013820A1 (en) 2000-08-11 2002-02-21 Ceramoptec Industries, Inc. Photosensitizing ointment
CN100488965C (en) 2001-06-01 2009-05-20 塞拉莫普泰克工业公司 Water soluble porphyrin derivatives for photodynamic therapy, their use and manufacture
IL152900A0 (en) * 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses

Also Published As

Publication number Publication date
CA2506296C (en) 2012-09-11
ES2489516T3 (en) 2014-09-02
CN1741801B (en) 2010-12-22
NO20052925L (en) 2005-06-15
NL300934I2 (en) 2018-05-22
JP5555659B2 (en) 2014-07-23
US20150238773A1 (en) 2015-08-27
CN1741801A (en) 2006-03-01
WO2004045492A2 (en) 2004-06-03
CA2506296A1 (en) 2004-06-03
DK1567147T3 (en) 2014-08-11
EP1567147A2 (en) 2005-08-31
AU2003282354C1 (en) 2009-10-29
RU2353624C2 (en) 2009-04-27
EP2522349A1 (en) 2012-11-14
JP2011148822A (en) 2011-08-04
JP4922559B2 (en) 2012-04-25
US20170143988A1 (en) 2017-05-25
CY2018012I2 (en) 2018-09-05
JP2011162551A (en) 2011-08-25
NO2018012I2 (en) 2018-04-10
HUS1800020I1 (en) 2018-05-28
AU2003282354A1 (en) 2004-06-15
NO334978B1 (en) 2014-08-11
PL376734A1 (en) 2006-01-09
AU2003282354B2 (en) 2009-04-23
NZ540790A (en) 2009-12-24
CN102002048A (en) 2011-04-06
CN102002048B (en) 2012-11-28
WO2004045492A3 (en) 2004-07-08
US20130345417A1 (en) 2013-12-26
US20110117029A1 (en) 2011-05-19
US7947672B2 (en) 2011-05-24
BRPI0316319B8 (en) 2021-05-25
RU2005118771A (en) 2006-01-20
EP1567147B1 (en) 2014-05-07
JP5566945B2 (en) 2014-08-06
US20060142260A1 (en) 2006-06-29
US20200094069A1 (en) 2020-03-26
IL168480A (en) 2015-01-29
BRPI0316319B1 (en) 2017-06-27
US8461142B2 (en) 2013-06-11
AU2003282354B8 (en) 2009-05-14
NO2018012I1 (en) 2018-04-10
HK1081858A1 (en) 2006-05-26
PT1567147E (en) 2014-08-25
PL216661B1 (en) 2014-04-30
EP1567147A4 (en) 2008-07-09
BE2018C018I2 (en) 2023-03-07
CY2018012I1 (en) 2018-09-05
CY1115458T1 (en) 2017-01-04
IL152900A0 (en) 2003-06-24
BR0316319A (en) 2005-09-27
LUC00073I2 (en) 2018-06-20
NO20052925D0 (en) 2005-06-15
JP2006515836A (en) 2006-06-08
MXPA05005262A (en) 2005-07-25
FR18C0002I2 (en) 2020-03-13

Similar Documents

Publication Publication Date Title
BE2017C049I2 (en)
BE2017C005I2 (en)
BE2018C018I2 (en)
BE2014C015I2 (en)
BE2013C063I2 (en)
BE2013C039I2 (en)
BE2013C025I2 (en)
BE2011C038I2 (en)
JP2003209483A5 (en)
JP2003161895A5 (en)
JP2003201610A5 (en)
JP2003195157A5 (en)
BRPI0302144B1 (en)
JP2003211308A5 (en)
BRPI0215435A2 (en)
BE2013C046I2 (en)
JP2003139190A5 (en)
JP2003137906A5 (en)
JP2003233954A5 (en)
JP2003208766A5 (en)
JP2003223623A5 (en)
DE60333342D1 (en)
JP2003187505A5 (en)
AU2001295323A1 (en)
AU2002226693A1 (en)